| 000 | 01548 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516055347.0 | ||
| 264 | 0 | _c20111108 | |
| 008 | 201111s 0 0 rus d | ||
| 022 | _a0022-9040 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBernhardt, Amj | |
| 245 | 0 | 0 |
_a[Diagnosis and options for reconstructive heart valve surgery in the Marfan syndrome]. _h[electronic resource] |
| 260 |
_bKardiologiia _c2011 |
||
| 300 |
_a85-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAortic Dissection _xetiology |
| 650 | 0 | 4 |
_aAorta _xpathology |
| 650 | 0 | 4 |
_aAortic Aneurysm _xetiology |
| 650 | 0 | 4 |
_aAortic Rupture _xetiology |
| 650 | 0 | 4 |
_aCardiovascular Surgical Procedures _xmethods |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aConnective Tissue _xpathology |
| 650 | 0 | 4 | _aFibrillin-1 |
| 650 | 0 | 4 | _aFibrillins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterdisciplinary Communication |
| 650 | 0 | 4 | _aLife Expectancy |
| 650 | 0 | 4 |
_aMarfan Syndrome _xcomplications |
| 650 | 0 | 4 |
_aMicrofilament Proteins _xgenetics |
| 650 | 0 | 4 |
_aMitral Valve Insufficiency _xetiology |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPatient-Centered Care _xstandards |
| 650 | 0 | 4 |
_aPractice Patterns, Physicians' _xstandards |
| 700 | 1 | _aTreede, H | |
| 700 | 1 | _aRybczynski, M | |
| 700 | 1 | _aSheikzadeh, S | |
| 700 | 1 | _aMeinertz, T | |
| 700 | 1 | _aReichenspurner, H | |
| 700 | 1 | _aKodolitsch, Y | |
| 773 | 0 |
_tKardiologiia _gvol. 51 _gno. 8 _gp. 85-90 |
|
| 999 |
_c21180625 _d21180625 |
||